John brings more than 25 years of pharmaceutical experience in drug discovery and drug development.
John manages drug substance chemical development across the portfolio including, Chemical, Manufacturing, and Controls (CMC), process development, non-GMP and cGMP manufacture, IND submission, CMC QA/QC integrated activities, and clinical trial API supply. Previously John held scientific and leadership positions at Confluence serving as Senior Principle Scientist in medicinal chemistry and Outsourcing Manager for Confluence Discovery Technologies since 2012 delivering irreversible covalent kinase inhibitors across the portfolio and compound generation for clients. Prior to Confluence John was a principal scientist in medicinal chemistry, chemistry outsourcing manager, and process chemist at Pfizer delivering clinical candidates in Inflammation/Immunology, cardiovascular, and oncology research therapeutic areas. He has co-authored peer-reviewed publications and is listed as an inventor on more than 17 patents.
John received his Bachelor of Arts in chemistry with minor in Biological Sciences and a Master of Science in chemistry from Southern Illinois University-Edwardsville. John also received his Master of Business Administration from Maryville University-St. Louis.
